APA (7th ed.) Citation

Terpos, E., Ntanasis-Stathopoulos, I., Katodritou, E., Kyrtsonis, M., Douka, V., Spanoudakis, E., . . . Atanackovic, D. (2021). Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study. Cancers, 13(6), 1257. https://doi.org/10.3390/cancers13061257

Chicago Style (17th ed.) Citation

Terpos, Evangelos, et al. "Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study." Cancers 13, no. 6 (2021): 1257. https://doi.org/10.3390/cancers13061257.

MLA (9th ed.) Citation

Terpos, Evangelos, et al. "Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study." Cancers, vol. 13, no. 6, 2021, p. 1257, https://doi.org/10.3390/cancers13061257.